Promise of pioneering research by Adrian Liston reported by Business Weekly
Business Weekly spoke to Adrian Liston about his research on reversing inflammation in brain disease. “The recent success of translating new immune-based therapeutics from mice to humans in immunological diseases and cancer demonstrates the high potential of using this new method to fight neurodegenerative disease” he said. The article explains how the new funding will help to translate Adrian’s work into treatments.
Read the full article online and explore the research in more detail: EU grant success to harness the immune system to treat brain damage.